Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,753
datasets available to search
ShareScore release 0.9.0
Dataset results
2,753 results for “NSCLC”
Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT05089734. IPD Sharing: NO. Countries: 20. Publications: 1.
A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)
ClinicalTrials.gov study NCT02411448. IPD Sharing: YES. Countries: 14. Publications: 13.
BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLC
ClinicalTrials.gov study NCT01243775. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Selumetinib in Patients Receiving Pemetrexed and Platinum-based Chemotherapy in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous NSCLC
ClinicalTrials.gov study NCT02337530. IPD Sharing: NO. Countries: 1. Publications: 1.
Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker in NSCLC
ClinicalTrials.gov study NCT03689855. IPD Sharing: NO. Countries: 1. Publications: 1.
Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC
ClinicalTrials.gov study NCT03822351. IPD Sharing: YES. Countries: 9. Publications: 2.
Radical Resection Vs. Ablative Stereotactic Radiotherapy in Patients With Operable Stage I NSCLC
ClinicalTrials.gov study NCT01753414. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC
ClinicalTrials.gov study NCT02504489. IPD Sharing: NO. Countries: 3. Publications: 1.
LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating Mutations
ClinicalTrials.gov study NCT00525148. IPD Sharing: Not stated. Countries: 2. Publications: 2.
BIBF 1120 in Combination With Pemetrexed in Advanced Non Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00979576. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC
ClinicalTrials.gov study NCT02387216. IPD Sharing: Not stated. Countries: 6. Publications: 1.
BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC)
ClinicalTrials.gov study NCT01562028. IPD Sharing: Not stated. Countries: 8. Publications: 4.
Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC
ClinicalTrials.gov study NCT00499109. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC
ClinicalTrials.gov study NCT00238615. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Osimertinib Treatment on EGFR T790M Plasma Positive NSCLC Patients (APPLE)
ClinicalTrials.gov study NCT02856893. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT03184571. IPD Sharing: YES. Countries: 4. Publications: 1.
Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC
ClinicalTrials.gov study NCT02197247. IPD Sharing: YES. Countries: 6. Publications: 1.
A Study of Necitumumab in the First-Line Treatment of Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT01763788. IPD Sharing: YES. Countries: 1. Publications: 1.
TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations
ClinicalTrials.gov study NCT04129502. IPD Sharing: YES. Countries: 24. Publications: 1.
Chemoradiation Followed by Durvalumab in Poor Risk and/or Elderly Patients With Stage III NSCLC
ClinicalTrials.gov study NCT04441138. IPD Sharing: NO. Countries: 1. Publications: 34.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.